VRTX:NASDAQ
Vertex Pharmaceuticals Inc
$508.34
0.00%
(0.00) 1D
Sep 18, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VRTX...
Mkt. cap
128.84B
Avg. vol.
1.09M
Volume
983.00
P/E ratio
29.58
52-wk high
$560.25
52-wk low
$374.17
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
Mkt. cap
128.84B
Avg. vol.
1.09M
Volume
983.00
P/E ratio
29.58
52-wk high
$560.25
52-wk low
$374.17
EPS
$17.19
Beta
0.32
Shares outstanding
253.46M
No. of employees
6K
News stories
From web sources and news partners
AD HOC NEWS
·
9 hours ago
Vertex Pharma stock slips 1.55 percent pre-market before the open
AD HOC NEWS
·
20 hours ago
Vertex Pharma stock consolidates after strong year-to-date gains
AD HOC NEWS
·
2 days ago
Vertex Pharmaceuticals stock gains on higher 2026 guidance
Yahoo Finance
·
2 days ago
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc
CEOReshma Kewalramani
Employees6.4K
Founded1989
HeadquartersBoston, Massachusetts, United States
SectorBiotechnology
Websitevrtx.com